David Bouchey
Stock Analyst at Aegis Capital
(0.13)
# 4,396
Out of 5,050 analysts
8
Total ratings
22.22%
Success rate
-45.26%
Average return
Main Sectors:
Stocks Rated by David Bouchey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SBFM Sunshine Biopharma | Reiterates: Buy | $7 | $1.72 | +306.98% | 3 | Oct 8, 2025 | |
| AEON AEON Biopharma | Reiterates: Buy | $7.2 | $0.91 | +694.09% | 1 | Oct 8, 2025 | |
| STSS Sharps Technology | Initiates: Buy | $105,600 | $3.86 | +2,735,651.30% | 1 | May 9, 2023 | |
| IINN Inspira Technologies Oxy B.H.N. | Maintains: Buy | $10 → $13 | $0.96 | +1,247.43% | 1 | Jan 25, 2023 | |
| RMTI Rockwell Medical | Downgrades: Outperform | $121 | $0.99 | +12,178.03% | 2 | Oct 19, 2018 |
Sunshine Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7
Current: $1.72
Upside: +306.98%
AEON Biopharma
Oct 8, 2025
Reiterates: Buy
Price Target: $7.2
Current: $0.91
Upside: +694.09%
Sharps Technology
May 9, 2023
Initiates: Buy
Price Target: $105,600
Current: $3.86
Upside: +2,735,651.30%
Inspira Technologies Oxy B.H.N.
Jan 25, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $0.96
Upside: +1,247.43%
Rockwell Medical
Oct 19, 2018
Downgrades: Outperform
Price Target: $121
Current: $0.99
Upside: +12,178.03%